Mast cell activation syndrome: a rare diagnosis, a common label.
Flushing, hives, racing heart, gut cramps. The symptoms are real. Whether mast cells are the whole story is a question worth asking carefully.
Mast cell activation syndrome (MCAS) is a condition in which mast cells, immune cells responsible for allergic reactions, release their chemicals inappropriately, causing episodes of hives, swelling, flushing, nausea, diarrhea, cramping, low blood pressure, rapid heart rate and wheezing. A confirmed diagnosis needs recurrent episodes involving at least two organ systems, a documented rise in a mast cell chemical such as tryptase during an episode, and a clear response to anti-mediator medication. The ATNS Index of Neuroplastic Symptoms notes that MCAS is rare, and that if the diagnosis is not definitive or the person does not respond to treatment as expected, neuroplastic symptoms should be considered and assessed. Neuroplastic symptoms are real, body-wide symptoms produced by a sensitized nervous system, and they respond to an approach that works with the brain.
This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.
Get the diagnosis right first
Mast cells are immune cells found in the skin, gut, airways and blood vessels. When triggered, they release histamine and other chemicals that produce the familiar signs of an allergic reaction. In mast cell activation syndrome, that release happens too easily or too often, producing episodes that can involve the skin (hives, flushing, itching, swelling), the gut (nausea, vomiting, cramping, diarrhea), the circulation (lightheadedness, fainting, racing heart) and the airways (wheezing, nasal congestion).
Because those symptoms overlap with many other conditions, international consensus criteria are strict. A diagnosis requires all three of: severe, recurrent episodes involving at least two organ systems; laboratory proof that mast cell chemicals rose during an episode, typically a tryptase level at least 20 percent plus 2 ng/mL above your own baseline; and a clear response to mast-cell-targeted medication such as antihistamines or stabilizers.
MCAS can be serious. Anaphylaxis-like episodes need emergency treatment, and anyone with suspected MCAS should be assessed by an allergist or immunologist who can run the tests and exclude mastocytosis and other causes.
The neuroplastic contribution
The ATNS Index of Neuroplastic Symptoms is careful here. It states that MCAS is rare. It does not say MCAS is neuroplastic. What it says is that if the diagnosis is not definitive, or if the person does not respond to treatment as expected, neuroplastic symptoms should be considered and assessed.
That caveat matters because MCAS has become a common label for a cluster of symptoms, often given without the laboratory confirmation the criteria require. Neuroplastic symptoms are real, physical symptoms produced by learned pathways in the brain and nervous system rather than by disease in the body. A sensitized nervous system can produce flushing, a racing heart, gut cramping, lightheadedness, itching and a sense of reacting to everything, because the autonomic nervous system controls blood vessels, gut movement and heart rate directly. The nervous system also talks to mast cells: stress hormones can trigger mast cells to release their contents. So an alarm system on high alert can create a picture that looks a great deal like MCAS.
- A confirmed MCAS diagnosis deserves proper medical treatment.
- An unconfirmed one deserves a second question: could this be the nervous system?
- Related entries: histamine intolerance, POTS and dysautonomia.
What the research shows
The 2021 updated consensus on diagnostic criteria and classification of mast cell disorders sets out the three-part definition above and emphasises that all three criteria must be met, precisely because clear criteria are needed to prevent both under- and over-diagnosis.
A 2024 study in the allergy literature noted that MCAS diagnoses have risen sharply since the syndrome was first described, and used symptom clustering to compare the consensus criteria with broader alternative criteria that some clinicians use. The broader criteria had low diagnostic specificity, meaning they capture many people whose symptoms are better explained by something else.
On the nervous-system side, a review of mast cell activation in brain injury, stress and post-traumatic stress disorder describes how stress releases corticotropin-releasing hormone, which activates mast cells and glial cells, and how neurons under stress release neuropeptides that trigger mast cells. This is largely mechanistic and animal work, but it shows the brain and mast cells are in constant conversation. No study has directly tested a neuroplastic approach in people labelled with MCAS; the index's recommendation rests on the rarity of true MCAS, the looseness of many diagnoses, and the capacity of a sensitized nervous system to produce the same symptoms.
Signs the brain may be part of the picture
- Your tryptase or other mediator tests have never shown a rise during an episode.
- Antihistamines and stabilizers have not changed the pattern as expected.
- Episodes follow stress, conflict, poor sleep or fear of a reaction more than exposure to a specific trigger.
- The list of foods, smells and substances you react to keeps growing.
- You also have fatigue, brain fog, widespread pain, dizziness on standing, irritable bowel or anxiety.
- Symptoms began during or after a period of major stress or illness.
Keep a two-column flare log for a week
Each time an episode starts this week, note two things in your phone: what you were exposed to, and what was happening in your life and your mind in the hour before (a difficult message, a deadline, a worry about reacting, poor sleep). Also rate your fear as the episode began, from 0 to 10. At the end of the week, read it back without judgement. You are giving yourself and your clinician honest data about how much of the pattern follows exposures and how much follows the nervous system.
A solution that addresses it
An approach exists that addresses the nervous-system contribution: pain and symptom reprocessing. It begins with education about neuroplastic symptoms, so that body-wide reactions can be understood as alarm rather than allergy where tests support that. It uses somatic tracking (observing flushing or a racing heart with curiosity instead of fear), practices that reduce the sense of threat, a graded re-expansion of the foods and places you have been avoiding, emotional awareness and expression, and acceptance and commitment skills. Trained clinicians deliver it, and digital programs increasingly support daily practice.
Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If your MCAS diagnosis has never felt definitive and treatment has not delivered, you can join the waitlist.
What to do next
Any episode with throat tightness, difficulty breathing, fainting or a sudden drop in blood pressure is an emergency: use an adrenaline auto-injector if you have one and call emergency services. Keep taking prescribed medication. Ask your allergist or immunologist whether your diagnosis meets the consensus criteria and whether baseline and episode tryptase have been measured.
If the diagnosis is uncertain or treatment is not working as expected, ask whether your symptoms could fit a neuroplastic pattern. If they might, start learning how a sensitized nervous system produces real symptoms, and begin gently retraining it. Our page on ME/CFS and ACT covers closely related territory.
Questions people ask
Is MCAS a neuroplastic condition?
No. True MCAS is a rare, laboratory-confirmed mast cell disorder. The ATNS index says that if the diagnosis is not definitive or treatment does not work as expected, neuroplastic symptoms should be considered and assessed, because a sensitized nervous system can produce very similar symptoms.
How is MCAS properly diagnosed?
Consensus criteria require recurrent episodes in at least two organ systems, a documented rise in a mast cell mediator such as tryptase during an episode compared with your baseline, and a clear response to mast-cell-targeted medication. All three must be met.
Can stress trigger mast cells?
Yes. Stress hormones and neuropeptides released by the nervous system can activate mast cells, which is one reason stress can bring on flushing or hives. That does not by itself mean a person has MCAS; it means the nervous system and the immune system are connected.
Does this mean I should stop my antihistamines?
No. Do not stop any prescribed medication without talking to your clinician. The neuroplastic approach can be practised alongside medical treatment, and any changes to medication should follow improvement, not precede it.
References
- Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal. Valent P et al., 2021. PMC8659997
- Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome criteria. 2024. PMC11700772
- Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis. PMC5733004
A daily companion for the hard days and the ordinary ones.
Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.
Join the waitlistThis article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.